Christine Brennan

Partner at Merck Research Ventures

Christine Brennan

Christine Brennan

Partner at Merck Research Ventures

Overview
Career Highlights

Novartis Institutes for BioMedical Research, Inc.

RelSci Relationships

3193

Number of Boards

6

Birthday

1968

Age

53

Relationships
RelSci Relationships are individuals Christine Brennan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at AMR Action Fund

Relationship likelihood: Strong

President & Chief Executive Officer at Entrada Therapeutics, Inc.

Relationship likelihood: Strong

Managing Partner at Avoro Capital Advisor LLC

Relationship likelihood: Strong

Managing Director at Novartis Venture Fund

Relationship likelihood: Strong

Managing Director at Novartis Venture Fund

Relationship likelihood: Strong

Managing Director at RA Capital Management LLC

Relationship likelihood: Strong

Managing Director at Novartis Venture Fund

Relationship likelihood: Strong

Managing Director at Novartis Venture Fund

Relationship likelihood: Strong

Partner at Merck Research Ventures

Relationship likelihood: Strong

Venture Partner at Novartis Venture Fund

Relationship likelihood: Strong

Paths to Christine Brennan
Potential Connections via
Relationship Science
You
Christine Brennan
Partner at Merck Research Ventures
Education
Ph.D. Unknown
Class of 1995

The Audrey and Theodor Geisel School of Medicine at Dartmouth, founded in 1797, strives to improve the lives of the people it serves: students, patients, and local and global communities. The School builds healthier communities through innovations in research, education, and patient care. As one of America's top medical schools, the Geisel School of Medicine is committed to creating physician leaders who will help solve our most vexing challenges in healthcare.

Career History
Partner
Current

Merck Research Ventures invests in therapeutics companies located globally with an investment size up to $15 million. The firm targets companies operating in the fields of pharma sectors. It provides seed and early stage capital requirements.

Partner
Tenure Unconfirmed

MRL Ventures Fund LLC, a subsidiary of Merck & Co., Inc., is an American company located in Cambridge, MA, that operates as a venture capital fund. The firm was founded by Max R. Levchin.

Professional
2013 - 2017

Novartis Venture Funds (USA) focuses on investments in early-stage opportunities in the following areas: (1) new therapeutics and platforms (2) medical devices and implants (3) diagnostics and biomarkers and (4) drug delivery and biopolymers. The firm looks for opportunities that address unmet medical needs, result in significant clinical impact, are based on novel proprietary science and are capital efficient. They prefer to make initial investments at the early stage. Their objective is to grow their portfolio companies and follow with additional investments as the company progresses. Novartis prefers to make total investments of $15 million to 420 million over the life of a company, but they may make investments of as little as $100,000 in start-up companies. The firm leads or co-leads their deals and remains open to participating in larger syndicates. Novartis invests in opportunities in the US, Canada, Europe, Switzerland and the Asia/Pacific region. The firm takes an active role in supporting through board or observer representation on their portfolio companies' boards of directors

Political Donations
$1,000
2015

MoveOn.org engages in promoting social and civic activities. Its services include education and advocacy on important national issues. The company was founded by by Joan Blades and Wes Boyd in 1998 and is headquartered in Greenbrae, CA.

$1,000
2012

Former President of United States

$700
2011

Former President of United States

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Christine Brennan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Christine Brennan's profile does not indicate a business or promotional relationship of any kind between RelSci and Christine Brennan.